A detailed history of Vanguard Personalized Indexing Management, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 6,840 shares of UTHR stock, worth $2.49 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
6,840
Previous 6,503 5.18%
Holding current value
$2.49 Million
Previous $2.07 Million 18.35%
% of portfolio
0.04%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$311.04 - $363.55 $104,820 - $122,516
337 Added 5.18%
6,840 $2.45 Million
Q2 2024

Aug 12, 2024

BUY
$228.26 - $319.04 $270,944 - $378,700
1,187 Added 22.33%
6,503 $2.07 Million
Q1 2024

May 09, 2024

SELL
$210.76 - $249.51 $350,493 - $414,935
-1,663 Reduced 23.83%
5,316 $1.22 Million
Q4 2023

Feb 07, 2024

BUY
$214.88 - $256.94 $129,357 - $154,677
602 Added 9.44%
6,979 $1.53 Million
Q3 2023

Nov 08, 2023

SELL
$211.82 - $248.24 $53,802 - $63,052
-254 Reduced 3.83%
6,377 $1.44 Million
Q2 2023

Jul 28, 2023

BUY
$205.19 - $232.99 $67,302 - $76,420
328 Added 5.2%
6,631 $1.46 Million
Q1 2023

May 10, 2023

SELL
$212.99 - $276.17 $24,706 - $32,035
-116 Reduced 1.81%
6,303 $1.41 Million
Q4 2022

Feb 10, 2023

BUY
$205.95 - $280.43 $9,061 - $12,338
44 Added 0.69%
6,419 $1.79 Million
Q3 2022

Nov 14, 2022

BUY
$203.3 - $244.17 $42,896 - $51,519
211 Added 3.42%
6,375 $1.34 Million
Q2 2022

Aug 09, 2022

BUY
$174.81 - $241.14 $645,398 - $890,288
3,692 Added 149.35%
6,164 $1.45 Million
Q1 2022

May 16, 2022

SELL
$166.16 - $213.96 $115,481 - $148,702
-695 Reduced 21.95%
2,472 $444,000
Q4 2021

Feb 23, 2022

BUY
$184.32 - $216.08 $207,175 - $242,873
1,124 Added 55.02%
3,167 $684,000
Q3 2021

Nov 09, 2021

BUY
$179.86 - $214.88 $159,535 - $190,598
887 Added 76.73%
2,043 $377,000
Q2 2021

Aug 11, 2021

BUY
$170.47 - $211.93 $197,063 - $244,991
1,156 New
1,156 $207,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.